BioSpace News Archive

Each September, the Foundation for Chiropractic Progress (F4CP), a not-for-profit organization dedicated to educating the public about the value of chiropractic care, sponsors National Drug-Free Pain Management Awareness Month.

Nikon Instruments Inc., innovator of advanced microscope systems and Abberior Instruments, the leading STED solution provider from the inventors of STED today announced a strategic partnership to accelerate adoption of easy-to-use STED technology in the US

Chrysalis BioTherapeutics, Inc. today announced that the Biomedical Advanced Research and Development Authority (BARDA), an agency of the US government’s Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response, has awarded Chrysalis a contract (HHSO100201900016C) to support the continued development of TP508,

First-of-its-kind research study shows increased emergency department workload to treat cannabis overdoses

As provider adoption of electronic health records (EHRs) approaches near-universal levels, a study from The Doctors Company shows the frequency of claims in which EHRs contributed to injury continues to rise.

Based on the successfully completed single-dose part of the phase I clinical trial in Korean population carried out by JW Pharmaceutical, LEO Pharma files IND application to the FDA for study of JW1601/LP0190 in US set to start in 2020.

Axonics Modulation Technologies, Inc. announced that members of the senior management team will present at the following upcoming investor conferences and will be available for meetings with institutional investors

Nanospectra Biosciences, Inc. announced publication of first in human data of the company’s AuroLase® Therapy for the focal ablation of prostate tissue.

Ionis Pharmaceuticals, Inc. announced that GSK exercised its option to license Ionis’ antisense medicines for people with chronic hepatitis B virus infection following positive Phase 2 results.

Castle Biosciences, Inc. announced that Derek Maetzold, President and Chief Executive Officer, is scheduled to present a company overview at the Baird 2019 Global Healthcare Conference in New York City on Wednesday, September 4, 2019, at 2:00 p.m. Eastern time.